Details for New Drug Application (NDA): 204707
✉ Email this page to a colleague
NDA 204707 describes PALIPERIDONE, which is a drug marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Alembic, Amneal Pharms, Ascent Pharms Inc, Cspc Ouyi, Dr Reddys, Everest Lifesciences, Inventia, Lupin Ltd, Rk Pharma, Sun Pharm, and Zydus Pharms, and is included in thirteen NDAs. It is available from eighteen suppliers. Additional details are available on the PALIPERIDONE profile page.
The generic ingredient in PALIPERIDONE is paliperidone. There are thirty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the paliperidone profile page.
The generic ingredient in PALIPERIDONE is paliperidone. There are thirty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the paliperidone profile page.
Summary for 204707
| Tradename: | PALIPERIDONE |
| Applicant: | Amneal Pharms |
| Ingredient: | paliperidone |
| Patents: | 0 |
Suppliers and Packaging for NDA: 204707
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PALIPERIDONE | paliperidone | TABLET, EXTENDED RELEASE;ORAL | 204707 | ANDA | AvKARE | 42291-915 | 42291-915-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-915-30) |
| PALIPERIDONE | paliperidone | TABLET, EXTENDED RELEASE;ORAL | 204707 | ANDA | AvKARE | 42291-916 | 42291-916-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-916-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1.5MG | ||||
| Approval Date: | Sep 23, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 3MG | ||||
| Approval Date: | Sep 23, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 6MG | ||||
| Approval Date: | Sep 23, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
